Contraception, popularly known as birth control or fertility control, is used to prevent pregnancy. There are various temporary and permanent contraceptive methods and devices available in the market. Sterilization is a permanent method that almost eliminates the chances of pregnancy. Temporary methods can either be hormonal or non-hormonal. Hormonal methods include oral contraceptive pills, contraceptive transdermal patches, vaginal rings, hormonal IUDs, and vaginal implants. These methods use synthetic sex hormones - estrogen, progestin, or a combination of both - to prevent ovulation and thicken the cervical mucus. Non-hormonal methods include condoms, cervical caps, diaphragms, non-hormonal IUDs, sponges, and withdrawal methods.
Technavio's analysts forecast the global female contraceptive market to grow at a CAGR of 3.0% over the period 2014-2019.
Covered in this report
This report covers the present scenario and the growth prospects of the global female contraceptive market for the period 2015-2019. This report considers 2014 as the base year and provides data for the trailing 12 months.This report covers the following types of female contraceptive:Devices (IUDs, Sterilization, Subdermal contraceptive implants, Vaginal rings, Female condoms, Non-surgical permanent contraception, Contraceptive diaphragms, and Contraceptive sponges)Drugs (Birth control pills and Emergency pills)
Technavio's report, Global Female Contraceptive Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, APAC, and EMEA; it also covers the landscape of the global female contraceptive market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Improved family planningFor a full, detailed list, view our report
Key market challenge
Lack of social acceptanceFor a full, detailed list, view our report
Key market trend
Increased unplanned pregnancyFor a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?What are the key market trends?What is driving this market?What are the challenges to market growth?Who are the key vendors in this market space?What are the market opportunities and threats faced by the key vendors?What are the strengths and weaknesses of the key vendors?
Technavio Announces the Publication of its Research Report – Global Female Contraceptives Market 2015-2019
Technavio recognizes the following companies as the key players in the Global Female Contraceptives Market: Allergan, Merck, Pfizer and Teva Pharmaceutical
Other Prominent Vendors in the market are: Ansell, Church & Dwight, Bayer, Agile Therapeutics, Caya, Fuji Latex, Janssen Pharmaceuticals, HLL Lifecare, Lipocine, Mayer Laboratories, Okamoto Industries, Reckitt Benckiser Group, Today Sponge and Female Health
Commenting on the report, an analyst from Technavio’s team said: “New contraceptives methods such as subdermal progestin implants, vaginal contraceptive rings, transdermal patches, and third-generation oral contraceptives are being increasing used by consumers. The market share for these methods is likely to increase during the forecast period, owing to their increased safety, convenience, and benefits. In addition, the development of MPTs that prevent both pregnancy and STIs are increasing.”
According to the report, the high demand for pills, the cheapest, easiest, and safest means of contraception, among individuals is driving the market.
Further, the report states that societal norms related to intimacy are discouraging consumers from openly buying these products, thereby hindering market growth.